#ExistRefRangeSet>
Reference Interval:
#ExistRefRange>Negative
*ExistRefRange>
|
*ExistRefRangeSet>
#ExistInterpDataSet>
| Interpretive Data: |
#ExistInterpData>This assay should not be used for blood donor screening, associated re-entry protocols, or for screening Human Cell, Tissues and Cellular and Tissue-Based Products (HCT/P).
*ExistInterpData>
|
*ExistInterpDataSet>
#ExistNote>
| Note: |
This test is recommended for specimens with prior low positive anti-HCV screening results. For high positive anti-HCV screening results, ARUP recommends collecting a new specimen and testing for hepatitis C RNA by PCR or bDNA. This test is intended for use in conjunction with clinical presentation and other laboratory markers as an indicator of disease prognosis. This test is also used as an aid in assessing viral response to antiretroviral treatment as measured by changes in HCV RNA levels.
|
*ExistNote>
#ExistCPT>
| CPT Code(s): |
86804
|
*ExistCPT>
#ExistCrossReferences>
Cross References: |
HCV RIBA (Hepatitis C Virus Antibody (RIBA), Supplemental), Recombinant Immunoblot Assay (Hepatitis C Virus Antibody (RIBA), Supplemental) |
*ExistCrossReferences>